Neurokinin3 receptor regulation of the airways

Vascular Pharmacology

Volumn 45, Issue 4, 2006, Pages 227-234

  Canning, Brendan J ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Asthma; Axon reflex; Capsaicin; Cough; Mucus; Parasympathetic; SB223412; SB235375; SR142801; Vagal

Indexed keywords

CAPSAICIN; NEUROKININ 3 RECEPTOR; NEUROKININ 3 RECEPTOR ANTAGONIST; NEUROKININ A; NEUROKININ B; NOLPITANTIUM; OSANETANT; SB 223956; SB 235375; SCH 206272; SENKTIDE; SSR 146977; SUBSTANCE P; TACHYKININ RECEPTOR ANTAGONIST; TALNETANT; UNCLASSIFIED DRUG; ZD 6021; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ASTHMA; BREATHING MUSCLE; CENTRAL NERVOUS SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEPOLARIZATION; DRUG MECHANISM; HUMAN; HYPERALGESIA; MUCUS GLAND; MUCUS SECRETION; NERVE CELL; NONHUMAN; PAIN; PARASYMPATHETIC GANGLION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RESPIRATION CONTROL; RESPIRATORY NERVE CELL; REVIEW; SENSITIZATION; SENSORY NERVE CELL; SMOOTH MUSCLE CONTRACTION; SYNAPTIC TRANSMISSION; VAGUS NERVE; VASCULARIZATION; ANIMAL; BIOLOGICAL MODEL; DRUG EFFECT; DRUG POTENTIATION; INNERVATION; LUNG; PHYSIOLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; LUNG; MODELS, NEUROLOGICAL; NEUROKININ A; NEUROTRANSMITTER AGENTS; RECEPTORS, NEUROKININ-3; SUBSTANCE P;

EID: 33751011886     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2005.08.031     Document Type: Review

References (109)

1. Advenier C., Naline E., Drapeau G., and Regoli D. Relative potencies of neurokinins in guinea pig trachea and human bronchus. Eur. J. Pharmacol. 139 2 (1987) 133-137 (Jul 9)
2. Advenier C., Naline E., Toty L., Bakdach H., Emonds-Alt X., Vilain P., Breliere J.C., and Le Fur G. Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptors. Am. Rev. Respir. Dis. 146 5 Pt 1 (1992) 1177-1181
3. Anthes J.C., Chapman R.W., Richard C., Eckel S., Corboz M., Hey J.A., et al. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist. Eur. J. Pharmacol. 450 2 (2002) 191-202
4. Bai T.R., Zhou D., Weir T., Walker B., Hegele R., Hayashi S., McKay K., Bondy G.P., and Fong T. Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases. Am. J. Physiol. 269 3 Pt 1 (1995) L309-L317
5. Baluk P., Nadel J.A., and McDonald D.M. Substance P-immunoreactive sensory axons in the rat respiratory tract: a quantitative study of their distribution and role in neurogenic inflammation. J. Comp. Neurol. 319 4 (1992) 586-598
6. Barbieri M., and Nistri A. Depression of windup of spinal neurons in the neonatal rat spinal cord in vitro by an NK3 tachykinin receptor antagonist. J. Neurophysiol. 85 4 (2001) 1502-1511
7. Barnes P.J. Asthma as an axon reflex. Lancet 1 8475 (1986) 242-245
8. Belvisi M.G., Patacchini R., Barnes P.J., and Maggi C.A. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences. Br. J. Pharmacol. 111 1 (1994) 103-110
9. Bertrand C., Nadel J.A., Graf P.D., and Geppetti P. Capsaicin increases airflow resistance in guinea pigs in vivo by activating both NK2 and NK1 tachykinin receptors. Am. Rev. Respir. Dis. 148 4 Pt 1 (1993) 909-914
10. Black J.L., Diment L.M., Alouan L.A., Johnson P.R., Armour C.L., Badgery-Parker T., and Burcher E. Tachykinin receptors in rabbit airways-characterization by functional, autoradiographic and binding studies. Br. J. Pharmacol. 107 2 (1992) 429-436
11. Canning B.J. Interactions between vagal afferent nerve subtypes mediating cough. Pulm. Pharmacol. Ther. 15 3 (2002) 187-192
12. Canning B.J., and Undem B.J. Evidence that antidromically stimulated vagal afferents activate inhibitory neurones innervating guinea-pig trachealis. J. Physiol. 480 Pt 3 (1994) 613-625
13. Canning B.J., Fischer A., and Undem B.J. Pharmacological analysis of the tachykinin receptors that mediate activation of nonadrenergic, noncholinergic relaxant nerves that innervate guinea pig trachealis. J. Pharmacol. Exp. Ther. 284 1 (1998) 370-377
14. Canning B.J., Reynolds S.M., and Mazzone S.B. Multiple mechanisms of reflex bronchospasm in guinea pigs. J. Appl. Physiol. 91 6 (2001) 2642-2653
15. Canning B.J., Reynolds S.M., Anukwu L.U., Kajekar R., and Myers A.C. Endogenous neurokinins facilitate synaptic transmission in guinea pig airway parasympathetic ganglia. Am. J. Physiol. Regul., Integr. Comp. Physiol. 283 2 (2002) R320-R330
16. D'Agostino G., Erbelding D., and Kilbinger H. Tachykinin NK(2) receptors facilitate acetylcholine release from guinea-pig isolated trachea. Eur. J. Pharmacol. 396 1 (2000) 29-32
17. Daoui S., Cui Y.Y., Lagente V., Emonds-Alt X., and Advenier C. A tachykinin NK3 receptor antagonist, SR 142801 (osanetant), prevents substance P-induced bronchial hyperreactivity in guinea-pigs. Pulm. Pharmacol. Ther. 10 5-6 (1997) 261-270
18. Daoui S., Cognon C., Naline E., Emonds-Alt X., and Advenier C. Involvement of tachykinin NK3 receptors in citric acid-induced cough and bronchial responses in guinea pigs. Am. J. Respir. Crit. Care Med. 158 1 (1998) 42-48
19. Daoui S., Naline E., Lagente V., Emonds-Alt X., and Advenier C. Neurokinin B- and specific tachykinin NK(3) receptor agonists-induced airway hyperresponsiveness in the guinea-pig. Br. J. Pharmacol. 130 1 (2000) 49-56
20. Daoui S., Ahnaou A., Naline E., Emonds-Alt X., Lagente V., and Advenier C. Tachykinin NK(3) receptor agonists induced microvascular leakage hypersensitivity in the guinea-pig airways. Eur. J. Pharmacol. 433 2-3 (2001) 199-207
21. Daoui S., D'Agostino B., Gallelli L., Alt X.E., Rossi F., and Advenier C. Tachykinins and airway microvascular leakage induced by HCl intra-oesophageal instillation. Eur. Respir. J. 20 2 (2002) 268-273
22. Dey R.D., Altemus J.B., Rodd A., Mayer B., Said S.I., and Coburn R.F. Neurochemical characterization of intrinsic neurons in ferret tracheal plexus. Am. J. Respir. Cell Mol. Biol. 14 3 (1996) 207-216
23. Ding Y.Q., Shigemoto R., Takada M., Ohishi H., Nakanishi S., and Mizuno N. Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat. J. Comp. Neurol. 364 2 (1996) 290-310
24. Drapeau G., D'Orleans-Juste P., Dion S., Rhaleb N.E., Rouissi N.E., and Regoli D. Selective agonists for substance P and neurokinin receptors. Neuropeptides 10 1 (1987) 43-54
25. Dreshaj I.A., Martin R.J., Miller M.J., and Haxhiu M.A. Responses of lung parenchyma and airways to tachykinin peptides in piglets. J. Appl. Physiol. 77 1 (1994) 147-151
26. Ellis J.L., Undem B.J., Kays J.S., Ghanekar S.V., Barthlow H.G., and Buckner C.K. Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster. J. Pharmacol. Exp. Ther. 267 1 (1993) 95-101
27. Ellis J.L., Sham J.S., and Undem B.J. Tachykinin-independent effects of capsaicin on smooth muscle in human isolated bronchi. Am. J. Respir. Crit. Care Med. 155 2 (1997) 751-755
28. Emonds-Alt X., Proietto V., Steinberg R., Advenier C., Daoui S., Naline E., Gueudet C., et al. Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist. Can. J. Physiol. Pharm. 80 5 (2002) 482-488
29. Fahy J.V., Wong H.H., Geppetti P., Reis J.M., Harris S.C., et al. Effect of an NK1 receptor antagonist (CP-99,994) on hypertonic saline-induced bronchoconstriction and cough in male asthmatic subjects. Am. J. Respir. Crit. Care Med. 152 3 (1995) 879-884
30. Faisy C., Naline E., Diehl J.L., Emonds-Alt X., Chinet T., and Advenier C. In vitro sensitization of human bronchus by beta2-adrenergic agonists. Am. J. Physiol., Lung Cell. Mol. Physiol. 283 5 (2002) L1033-L1042
31. Figini M., Emanueli C., Bertrand C., Javdan P., and Geppetti P. Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor. Br. J. Pharmacol 117 6 (1996) 1270-1276
32. Fischer A., and Hoffmann B. Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia of man. Correlation with neuropeptides. Am. J. Respir. Crit. Care Med. 154 1 (1996) 209-216
33. Fontan J.J., Cortright D.N., Krause J.E., Velloff C.R., Karpitskyi V.V., Carver Jr. T.W., Shapiro S.D., and Mora B.N. Substance P and neurokinin-1 receptor expression by intrinsic airway neurons in the rat. Am. J. Physiol., Lung Cell. Mol. Physiol. 278 2 (2000) L344-L355
34. Fry B., Reifsteck A., Hoover D.B., and Williams C.A. NK(3) receptors in the feline nucleus tractus solitarius are not involved with the muscle pressor response. Neuropeptides 35 (2001) 154-161
35. Fu L., Kaneko T., Ikeda H., Nishiyama H., Suzuki S., Okubo T., et al. Tachykinins via tachykinin NK(2) receptor activation mediate ozone-induced increase in the permeability of the tracheal mucosa in guinea-pigs. Br. J. Pharmacol. 135 5 (2002) 1331-1335
36. Fuller R.W., Dixon C.M., and Barnes P.J. Bronchoconstrictor response to inhaled capsaicin in humans. J. Appl. Physiol. 58 4 (1985) 1080-1084
37. Geraghty D.P., and Mazzone S.B. Tachykinin receptor (NK(1), NK(2), NK(3)) binding sites in the rat caudal brainstem following neonatal capsaicin administration. Brain Res. 979 1-2 (2003) 230-234
38. Grandordy B.M., Frossard N., Rhoden K.J., and Barnes P.J. Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction. Mol. Pharmacol. 33 5 (1988) 515-519
39. Grant A.D., Akhtar R., Gerard N.P., and Brain S.D. Neurokinin B induces oedema formation in mouse lung via tachykinin receptor-independent mechanisms. J. Physiol. 543 Pt 3 (2002) 1007-1014
40. Grundstrom N., Andersson R.G., and Wikberg J.E. Pharmacological characterization of the autonomous innervation of the guinea pig tracheobronchial smooth muscle. Acta Pharm. Toxicol. (Copenh.) 49 2 (1981) 150-157
41. Halldorsdottir H., Greiff L., Wollmer P., Andersson M., Svensson C., Alkner U., and Persson C.G. Effects of inhaled histamine, methacholine and capsaicin on sputum levels of alpha 2 macroglobulin. Thorax 52 11 (1997) 964-968
42. Harrison T.A., Hoover D.B., and King M.S. Distinct regional distributions of NK1 and NK3 neurokinin receptor immunoreactivity in rat brainstem gustatory centers. Brain Res. Bull. 63 1 (2004) 7-17
43. Hay D.W., Giardina G.A., Griswold D.E., Underwood D.C., Kotzer C.J., et al. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs. J. Pharmacol. Exp. Ther. 300 1 (2002) 314-323
44. Howarth P.H., Springall D.R., Redington A.E., Djukanovic R., Holgate S.T., and Polak J.M. Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and nonasthmatic subjects. Am. J. Respir. Cell Mol. Biol. 13 3 (1995) 288-296
45. Hua X.Y., Theodorsson-Norheim E., Brodin E., Lundberg J.M., and Hokfelt T. Multiple tachykinins (neurokinin A, neuropeptide K and substance P) in capsaicin-sensitive sensory neurons in the guinea-pig. Regul Pept. 13 1 (1985) 1-19
46. Ichinose M., Miura M., Yamauchi H., Kageyama N., Tomaki M., et al. A neurokinin 1-receptor antagonist improves exercise-induced airway narrowing in asthmatic patients. Am. J. Respir. Crit. Care Med. 153 3 (1996) 936-941
47. Joos G.F., Germonpre P.R., and Pauwels R.A. Neurogenic inflammation in human airways: is it important?. Thorax 50 3 (1995) 217-219
48. Joos G.F., Van Schoor J., Kips J.C., and Pauwels R.A. The effect of inhaled FK224, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction in asthmatics. Am. J. Respir. Crit. Care Med. 153 6 Pt 1 (1996) 1781-1784
49. Joos G.F., Lefebvre R.A., Bullock G.R., and Pauwels R.A. Role of 5-hydroxytryptamine and mast cells in the tachykinin-induced contraction of rat trachea in vitro. Eur. J. Pharmacol. 338 3 (1997) 259-268
50. Joos G.F., Vincken W., Louis R., Schelfhout V.J., Wang J.H., Shaw M.J., Cioppa G.D., and Pauwels R.A. Dual tachykinin NK1/NK2 antagonist DNK333 inhibits neurokinin A-induced bronchoconstriction in asthma patients. Eur. Respir. J. 23 1 (2004) 76-81
51. Kim J.S., Rabe K.F., Magnussen H., Green J.M., and White S.R. Migration and proliferation of guinea pig and human airway epithelial cells in response to tachykinins. Am. J. Physiol. 269 1 Pt 1 (1995) L119-L126
52. Kummer W., Fischer A., Kurkowski R., and Heym C. The sensory and sympathetic innervation of guinea-pig lung and trachea as studied by retrograde neuronal tracing and double-labelling immunohistochemistry. Neuroscience 49 3 (1992) 715-737
53. Kung T.T., Crawley Y., Jones H., Luo B., Gilchrest H., Greenfeder S., et al. Tachykinin NK3-receptor deficiency does not inhibit pulmonary eosinophilia in allergic mice. Pharmacol. Res. 50 6 (2004) 611-615
54. Lamb J.P., and Sparrow M.P. Three-dimensional mapping of sensory innervation with substance p in porcine bronchial mucosa: comparison with human airways. Am. J. Respir. Crit. Care Med. 166 9 (2002) 1269-1281
55. Lee L.Y., Shuei Lin Y., Gu Q., Chung E., and Ho C.Y. Functional morphology and physiological properties of bronchopulmonary C-fiber afferents. Anat. Rec. A Discov. Mol. Cell Evol. Biol. 270 1 (2003) 17-24
56. Lei Y.H., Barnes P.J., and Rogers D.F. Inhibition of neurogenic plasma exudation in guinea-pig airways by CP-96,345, a new non-peptide NK1 receptor antagonist. Br. J. Pharmacol. 105 2 (1992) 261-262
57. Linden D.R., and Seybold V.S. Spinal neurokinin3 receptors mediate thermal but not mechanical hyperalgesia via nitric oxide. Pain 80 1-2 (1999) 309-317
58. Linden D.R., Jia Y.P., and Seybold V.S. Spinal neurokin3 receptors facilitate the nociceptive flexor reflex via a pathway involving nitric oxide. Pain 80 1-2 (1999) 301-308
59. Lundberg J.M., and Saria A. Capsaicin-sensitive vagal neurons involved in control of vascular permeability in rat trachea. Acta Physiol. Scand. 115 4 (1982) 521-523
60. Lundberg J.M., and Saria A. Bronchial smooth muscle contraction induced by stimulation of capsaicin-sensitive sensory neurons. Acta Physiol. Scand. 116 4 (1982) 473-476
61. Lundberg J.M., Hokfelt T., Martling C.R., Saria A., and Cuello C. Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res. 235 2 (1984) 251-261
62. Maggi C.A., Patacchini R., Perretti F., Tramontana M., Manzini S., Geppetti P., and Santicioli P. Sensory nerves, vascular endothelium and neurogenic relaxation of the guinea-pig isolated pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 342 1 (1990) 78-84
63. Maghni K., Michoud M.C., Alles M., Rubin A., Govindaraju V., et al. Airway smooth muscle cells express functional neurokinin-1 receptors and the nerve-derived preprotachykinin-a gene: regulation by passive sensitization. Am. J. Respir. Cell Mol. Biol. 28 1 (2003) 103-110
64. Manzini S. Bronchodilatation by tachykinins and capsaicin in the mouse main bronchus. Br. J. Pharmacol. 105 4 (1992) 968-972
65. Mazzone S.B., and Canning B.J. Central nervous system control of the airways: pharmacological implications. Curr. Opin. Pharmacol. 2 3 (2002) 220-228
66. Mazzone S.B., and Canning B.J. Synergistic interactions between airway afferent nerve subtypes mediating reflex bronchospasm in guinea pigs. Am. J. Physiol. Regul., Integr. Comp. Physiol. 283 1 (2002) R86-R98
67. Mazzone S.B., and Canning B.J. Tachykinin NK3 receptor antagonists. In: Holzer P. (Ed). Handbook of Experimental Pharmacology, Volume 164, Tachykinins (2004), Springer, Berlin
68. Mazzone S.B., and Geraghty D.P. Respiratory action of capsaicin microinjected into the nucleus of the solitary tract: involvement of vanilloid and tachykinin receptors. Br. J. Pharmacol. 127 2 (1999) 473-481
69. Mazzone S.B., and Geraghty D.P. Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists. Br. J. Pharmacol. 129 6 (2000) 1121-1131
70. Mazzone S.B., Mori N., and Canning B.J. Synergistic interactions between airway afferent nerve subtypes regulating the cough reflex in guinea-pigs. J. Physiol. 569 Pt 2 (2005) 559-573
71. McCormack D.G., Salonen R.O., and Barnes P.J. Effect of sensory neuropeptides on canine bronchial and pulmonary vessels in vitro. Life Sci. 45 25 (1989) 2405-2412
72. McDonald D.M. Neurogenic inflammation in the rat trachea. I. Changes in venules, leucocytes and epithelial cells. J. Neurocytol. 17 5 (1988) 583-603
73. McDonald D.M., Mitchell R.A., Gabella G., and Haskell A. Neurogenic inflammation in the rat trachea. II. Identity and distribution of nerves mediating the increase in vascular permeability. J. Neurocytol. 17 5 (1988) 605-628
74. Moreaux B., Nemmar A., Vincke G., Halloy D., Beerens D., Advenier C., and Gustin P. Role of substance P and tachykinin receptor antagonists in citric acid-induced cough in pigs. Eur. J. Pharmacol. 408 3 (2000) 305-312
75. Moreaux B., Advenier C., and Gustin P. Role of bradykinin and tachykinins in the potentiation by enalapril of coughing induced by citric acid in pigs. Fundam. Clin. Pharmacol. 15 1 (2001) 23-29
76. Moussaoui S.M., Le Prado N., Bonici B., Faucher D.C., Cuine F., et al. Distribution of neurokinin B in rat spinal cord and peripheral tissues: comparison with neurokinin A and substance P and effects of neonatal capsaicin treatment. Neuroscience 48 4 (1992) 969-978
77. Mukaiyama O., Morimoto K., Nosaka E., Takahashi S., and Yamashita M. Involvement of enhanced neurokinin NK3 receptor expression in the severe asthma guinea pig model. Eur. J. Pharmacol. 498 1-3 (2004) 287-294
78. Murai M., Morimoto H., Maeda Y., Kiyotoh S., Nishikawa M., and Fujii T. Effects of FK224, a novel compound NK1 and NK2 receptor antagonist, on airway constriction and airway edema induced by neurokinins and sensory nerve stimulation in guinea pigs. J. Pharmacol. Exp. Ther. 262 1 (1992) 403-408
79. Myers A.C., and Undem B.J. Electrophysiological effects of tachykinins and capsaicin on guinea-pig bronchial parasympathetic ganglion neurones. J. Physiol. 470 (1993) 665-679
80. Myers A., Undem B., and Kummer W. Anatomical and electrophysiological comparison of the sensory innervation of bronchial and tracheal parasympathetic ganglion neurons. J. Auton. Nerv. Syst. 61 2 (1996) 162-168
81. Myers A.C., Goldie R.G., and Hay D.W. A novel role for tachykinin neurokinin-3 receptors in regulation of human bronchial ganglia neurons. Am. J. Respir. Crit. Care Med. 171 (2005) 212-216
82. Nagaki M., Ishihara H., Shimura S., Sasaki T., Takishima T., and Shirato K. Tachykinins induce a [Ca2+]i rise in the acinar cells of feline tracheal submucosal gland. Respir. Physiol. 98 1 (1994) 111-120
83. Naline E., Devillier P., Drapeau G., Toty L., Bakdach H., Regoli D., and Advenier C. Characterization of neurokinin effects and receptor selectivity in human isolated bronchi. Am. Rev. Respir. Dis. 140 3 (1989) 679-686
84. Nenan S., Germain N., Lagente V., Emonds-Alt X., Advenier C., and Boichot E. Inhibition of inflammatory cell recruitment by the tachykinin NK(3)-receptor antagonist, SR 142801, in a murine model of asthma. Eur. J. Pharmacol. 421 3 (2001) 201-205
85. Pedersen K.E., Buckner C.K., Meeker S.N., and Undem B.J. Pharmacological examination of the neurokinin-1 receptor mediating relaxation of human intralobar pulmonary artery. J. Pharmacol. Exp. Ther. 292 1 (2000) 319-325
86. Phillips J.E., Hey J.A., and Corboz M.R. Tachykinin NK3 and NK1 receptor activation elicits secretion from porcine airway submucosal glands. Br. J. Pharmacol. 138 1 (2003) 254-260
87. Pinto F.M., Saulnier J.P., Faisy C., Naline E., Molimard M., Prieto L., Martin J.D., et al. SR 142801, a tachykinin NK(3) receptor antagonist, prevents beta(2)-adrenoceptor agonist-induced hyperresponsiveness to neurokinin A in guinea-pig isolated trachea. Life Sci. 72 (2002) 307-320
88. Pinto F.M., Almeida T.A., Hernandez M., Devillier P., Advenier C., and Candenas M.L. mRNA expression of tachykinins and tachykinin receptors in different human tissues. Eur. J. Pharmacol. 494 2-3 (2004) 233-239
89. Reynolds P.N., Scicchitano R., and Holmes M.D. Pre-protachykinin-A mRNA is increased in the airway epithelium of smokers with chronic bronchitis. Respirology 6 3 (2001) 187-197
90. Rogers D.F. Motor control of airway goblet cells and glands. Respir. Physiol. 125 (2001) 129-144
91. Rogers D.F., Belvisi M.G., Aursudkij B., Evans T.W., and Barnes P.J. Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea-pigs. Br. J. Pharmacol. 95 4 (1988) 1109-1116
92. Rogers D.F., Aursudkij B., and Barnes P.J. Effects of tachykinins on mucus secretion in human bronchi in vitro. Eur. J. Pharmacol. 174 2-3 (1989) 283-286
93. Sarau H.M., Mooney J.L., Schmidt D.B., Foley J.J., Buckley P.T., Giardina G.A., et al. Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin. Mol. Pharmacol. 58 3 (2000) 552-559
94. Sarau H.M., Feild J.A., Ames R.S., Foley J.J., Nuthulaganti P., Schmidt D.B., Buckley P.T., Elshourbagy N.A., Brawner M.E., Luttmann M.A., Giardina G.A., and Hay D.W. Molecular and pharmacological characterization of the murine tachykinin NK(3) receptor. Eur. J. Pharmacol. 413 (2001) 143-150
95. Saria A., Martling C.R., Yan Z., Theodorsson-Norheim E., Gamse R., and Lundberg J.M. Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am. Rev. Respir. Dis. 137 6 (1988) 1330-1335
96. Satoh H., Lou Y.P., Lee L.Y., and Lundberg J.M. Inhibitory effects of capsazepine and the NK2 antagonist SR 48968 on bronchoconstriction evoked by sensory nerve stimulation in guinea-pigs. Acta Physiol. Scand. 146 4 (1992) 535-536
97. Schelfhout V., Louis R., Lenz W., Heyrman R., Pauwels R., and Joos G. The triple neurokinin-receptor antagonist CS-003 inhibits neurokinin A-induced bronchoconstriction in patients with asthma. Pulm. Pharmacol. Ther. (2005) [Electronic publication]
98. Schmid G., Carita F., Bonanno G., and Raiteri M. NK-3 receptors mediate enhancement of substance P release from capsaicin-sensitive spinal cord afferent terminals. Br. J. Pharmacol. 125 (1998) 621-626
99. Shughrue P.J., Lane M.V., and Merchenthaler I. In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous system. J. Comp. Neurol. 372 3 (1996) 395-414
100. Smith M.E., and Flynn F.W. Distribution of Fos-like immunoreactivity within the rat brain following intraventricular injection of the selective NK(3) receptor agonist senktide. J. Comp. Neurol. 426 3 (2000) 413-428
101. Springer J., Groneberg D.A., Pregla R., and Fischer A. Inflammatory cells as source of tachykinin induced mucus secretion in chronic bronchitis. Regul Pept. 124 1-3 (2005) 195-201
102. Szarek J.L., Stewart N.L., Spurlock B., and Schneider C. Sensory nerve- and neuropeptide-mediated relaxation responses in airways of Sprague-Dawley rats. J. Appl. Physiol. 78 5 (1995) 1679-1687
103. Tamaoki J., Sakai A., Kondo M., Takemura H., and Konno K. Role of nitric oxide in tachykinin-induced increase in potential difference of rabbit tracheal mucosa. J. Physiol. 488 (1995) 115-122
104. Tamaoki J., Kondo M., Sakai A., Tagaya E., Takemura H., and Konno K. Tachykinins stimulate nitric oxide generation by canine cultured tracheal epithelium. Regul Pept. 60 1 (1995) 55-60
105. Uchida Y., Nomura A., Ohtsuka M., Hasegawa S., Goto K., Kimura S., Sugita Y., and Uchiyama Y. Neurokinin A as a potent bronchoconstrictor. Am. Rev. Respir. Dis. 136 3 (1987) 718-721
106. Van Schoor J., Joos G.F., Chasson B.L., Brouard R.J., and Pauwels R.A. The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics. Eur. Respir. J. 12 1 (1998) 17-23
107. Wagner U., Fehmann H., Bredenbroker D., Kluber D., Lange A., and Wichert P. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat. Neuropeptides 33 1 (1999) 55-61
108. Yu X.Y., Undem B.J., and Spannhake E.W. Protective effect of substance P on permeability of airway epithelial cells in culture. Am. J. Physiol. 271 6 Pt 1 (1996) L889-L895
109. Zaratin P., Angelici O., Clarke G.D., Schmid G., Raiteri M., Carita F., and Bonanno G. NK3 receptor blockade prevents hyperalgesia and the associated spinal cord substance P release in monoarthritic rats. Neuropharmacology 39 1 (2000) 141-149